Cargando…
HMGB1 genetic polymorphisms are biomarkers for the development and progression of breast cancer
Breast cancer is a major cause of cancer mortality worldwide. High-mobility group box protein 1 (HMGB1) is a ubiquitous nuclear protein found in all mammal eukaryotic cells that participates in tumor progression, migration and metastasis. HMGB1 overexpression has been indicated in breast cancer pati...
Autores principales: | Huang, Bi-Fei, Tzeng, Huey-En, Chen, Po-Chun, Wang, Chao-Qun, Su, Chen-Ming, Wang, Yan, Hu, Gui-Nv, Zhao, Yong-Ming, Wang, Qian, Tang, Chih-Hsin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5930459/ https://www.ncbi.nlm.nih.gov/pubmed/29725248 http://dx.doi.org/10.7150/ijms.23462 |
Ejemplares similares
-
Correlation between CCL4 gene polymorphisms and clinical aspects of breast cancer
por: Hu, Gui-Nv, et al.
Publicado: (2018) -
FSCN1 gene polymorphisms: biomarkers for the development and progression of breast cancer
por: Wang, Chao-Qun, et al.
Publicado: (2017) -
Impacts of RETN genetic polymorphism on breast cancer development
por: Wang, Chao-Qun, et al.
Publicado: (2020) -
Effects of HMGB1 Polymorphisms on the Susceptibility and Progression of Hepatocellular Carcinoma
por: Wang, Bin, et al.
Publicado: (2016) -
Association of HMGB1 Gene Polymorphisms with Lung Cancer Susceptibility and Clinical Aspects
por: Hu, Weiwei, et al.
Publicado: (2017)